TR
Trinity Biotech plc
TRIB · NASDAQ
$7.35 +2.23% (+$0.16)
1M -28.85%
Market Cap $7.44M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$8.61
17.1% upside
Trenutna cena
$7.35
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica TRIB trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.17x
P/FFO N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 11.10%
FCF growth N/A
Book val. growth N/A
Profitability
14 /100
Weak Net margin 85.32%
Op. margin 25.66%
FCF margin 14.46%
Quality
7 /100
Poor ROA 35.59%
Asset turnover 0.42x
ROIC 15.14%
Debt
0 /100
High Int. coverage -0.53x
Current ratio 0.25x
Net debt/EBITDA N/A
Stability
61 /100
Moderate Rev. volatility 18.49%
EPS volatility 31.66%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TRIB
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
John Gillard
Employees
287
Headquarters
Bray
Prihajajoči dogodki
10 DEC.
Earnings
Upcoming earnings report